Tonantzitlolone is a natural agonist of tprc1 4 5 channels, also acting as a dual pkcα and pkcθ activator, inducing an insulin resistant phenotype by inhibiting irs1 and the pi3k akt pathway, activating the heat shock factor 1 (hsf1) transcription factor driving glucose dependency